Enlivex Therapeutics Ltd. (FRA:1BT)
0.9400
-0.0450 (-4.57%)
Last updated: Jan 29, 2026, 8:04 AM CET
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of €201.8 million as of January 30, 2026. Its market cap has increased by 721.09% in one year.
Market Cap
201.80M
Enterprise Value
187.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.94
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has increased from 90.03M to 201.80M, an increase of 124.14%. That is a compound annual growth rate of 12.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 201.80M | 41.94% |
| Dec 31, 2025 | 142.17M | 472.11% |
| Dec 31, 2024 | 24.85M | -45.30% |
| Dec 29, 2023 | 45.43M | -33.03% |
| Dec 30, 2022 | 67.83M | -32.66% |
| Dec 31, 2021 | 100.74M | 1.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EUWAX Aktiengesellschaft | 257.50M |
| centrotherm international AG | 232.79M |
| STINAG Stuttgart Invest AG | 232.23M |
| Sino AG | 229.08M |
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 208.56M |
| Allane SE | 204.05M |
| Eleving Group | 186.27M |
| ADM Hamburg Aktiengesellschaft | 173.72M |